Combined_Synopsis_Solicitation-COMPETITIVE.pdf

COMBINED SYNOPSIS / SOLICITATION

COMPETITIVE

Title: Acell Robotrack Assay-Ready Plate

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

(ii) The solicitation number is HHS-NIH-NIDA-SSSA-CSS-2017-599 and the solicitation is issued as a request for quotation (RFQ).

This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; FAR Subpart 13.5— Simplified Procedures for Certain Commercial Items;

and FAR Part 12—Acquisition of Commercial Items, and is expected to exceed the simplified acquisition threshold.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-95 dated 01-19-2017.

(iv) The associated NAICS code 333249 – Other Industrial Machinery Manufacturing and the small business size standard is 500 employees. This requirement is solicited as a full and open competition with no set-side restrictions.

(v) Refer to the attached Purchase Description for project requirements.

The National Center for Advancing Translational Sciences (NCATS) has invested hundreds of thousands of dollars in several acoustic dispensing instruments. These instruments are capable of transferring small volumes of liquid (in the nL range) from a source plate to a destination of plate of any well density. These capabilities have enabled the establishment of Matrix screening where multiple compounds or drugs are screened against one another in a dose response fashion. Over time this has become a standard method of screening at NCATS and is one of the core technologies provided by the Research Service and Support (RSS) group. Over time, the adoption of acoustic dispensing has grown beyond just being used for Matrix screening to a variety of other applications, increasing the need for a diverse set of instruments to keep up with growing demand. This demand became even more pressing upon completion of the NIH Small Molecule Repository contract (HHSN271201200003I-HHSN27100001) with the work previously being performed by Evotec Inc. now becoming the responsibility of NCATS.

A key piece of equipment put into use during the course of the contract was a LabCyte Echo acoustic dispenser which has now become a critical component of a variety of RSS operations involving the creation of assay ready plates.

The purpose of this acquisition is to obtain a fully automated robotic workstation capable of performing cherry-picking, dose-response (in both single and multiple agent fashion), reformatting and replication of compound libraries using acoustic dispense technology into SBS-standard microplates.

(vi) Refer to attached Purchase Description and Evaluation Criteria documents for additional details.

(vii) Anticipated period of performance: Work to begin 30 days ARO

(viii) The provision at FAR clause 52.212-1, Instructions to Offerors – Commercial Items, applies to this acquisition.

(ix) The provision at FAR clause 52.212-2, Evaluation – Commercial Items, applies to this acquisition.

(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: Factor 1: Technical Capability; Factor 2: Key Personnel Qualifications; Factor 3: Past Performance; Factor 4: Cost/Price. Proposals will be evaluated using a summary adjectival rating scale. Refer to Evaluation Criteria document for details. Technical and past performance, when combined, are significantly more important than cost or price.

(b) Options. N/A

(c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.

(x) The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications—Commercial Items, with its offer.

(xi) The FAR clause at 52.212-4, Contract Terms and Conditions – Commercial Items, applies to this acquisition.

(xii) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders–Commercial Items, applies to this acquisition. Refer to attached Addendum.

(xiii) The following additional contract requirement(s) or terms and conditions as determined by the contracting officer are necessary for this acquisition and consistent with customary commercial practices. There are no additional contract requirements or terms and conditions applicable to this acquisition.

(xiv) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.

(xv) Responses to this solicitation must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement as it relates to the technical evaluation criteria.

The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount.

In addition the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.”

All responses must be received by August 02, 2017 at 9 a.m. ET and reference number HHS-NIH-NIDA-SSSA-CSS-2017-599. Responses may be submitted electronically to Rachelle Trice at Rachelle.Trice@nih.gov.

Fax responses will not be accepted.

http://www.sam.gov/